Specifica Publications

A pandemic-enabled comparison of discovery platforms demonstrates a naive antibody library can match the best immune-sourced antibodies

Fortunato Ferrara,
M. Frank Erasmus,
Sara D’Angelo,
Camila Leal-Lopes,
Andre A. Teixeira,
Alok Choudhary,
William Honnen,
David Calianese,
Deli Huang,
Linghan Peng,
James E. Voss,
David Nemazee,
Dennis R. Burton,
Abraham Pinter,
Andrew R.M. Bradbury,

2022 | Nature Communications

View Publication

Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries

Andre A. Teixeira,
M. Frank Erasmus,
Sara D’Angelo,
Leslie Naranjo,
Fortunato Ferrara,
Camila Leal-Lopes,
Oliver Durrant,
Cecile Galmiche,
Aleardo Morelli,
Anthony Scott-Tucker,
Andrew R.M. Bradbury,

2021 | mAbs

View Publication

Construction, characterization and crystal structure of a fluorescent single-chain Fv chimera

Nileena Velappan,
Devin Close,
Li-Wei Hung,
Leslie Naranjo,
Colin Hemez,
Natasha DeVore,
Donna McCullough,
Antonietta M. Lillo,
Geoffrey S. Waldo,
Andrew R.M. Bradbury,

2021 | peds

View Publication

A single donor is sufficient to produce a highly functional in vitro antibody library

M. Frank Erasmus,
Sara D’Angelo,
Fortunato Ferrara,
Leslie Naranjo,
Andre Teixeira,
Rebecca Buonpane,
Shaun M. Stewart,
Nastri G. Horacio,
Andrew R.M. Bradbury,

2021 | Communications Biology

View Publication

Selection and characterization of Fc epsilon R1 phospho-ITAM specific antibodies

Nileena Velappan,
Avnika Mahajan,
Leslie Naranjo,
Prianka Velappan,
Nasim Andrews,
Nick Tiee,
Subhendu Chakraborti,
Colin Hemez,
Tiziano Gaiotto,
Bridget Wilson,
Andrew Bradbury,

2019 | MAbs: 1-13

View Publication

Recombinant antibodies against mycolactone

Leslie Naranjo,
Fortunato Ferrara,
Nicolas Blanchard,
Caroline Demangel,
Sara D’Angelo,
M. Frank Erasmus,
André Teixeira,
Andrew Bradbury,

2019 | Toxins (Basel) 11(6)

View Publication

Rapid purification of billions of circulating CD19+ cells directly from leukophoresis samples

Fortunato Ferrara,
Martin Kolnik,
Sara D’Angelo,
M. Frank Erasmus,
André Teixeira,
Daniela Vorholt,
Andrew Bradbury,

2018 | N Biotechnol 46

View Publication

When monoclonal antibodies are not monospecific: hybridomas frequently express additional functional variable regions

Andrew Bradbury,
Nathan Trinklein,
Holger Thie,
Ian Wilkinson,
Atul Tandon,
Stephen Anderson,
Catherine Bladen,
Brittany Jones,
Shelly Force Aldred,
Marco Bestagno,
Oscar Burrone,
Jennifer Maynard,
Fortunato Ferrara,
James Trimmer,
Janina Görnemann,
Jacob Glanville,
Philipp Wolf,
Andre Frenzel,
Julin Wong,
Xin Yu Koh,
Hui-Yan Eng,
David Lane,
Marie-Paule Lefrance,
Mike Clark,
Stefan Dübel,

2018 | MAbs 10 1-19

View Publication

Selection of phage displayed accessible recombinant targeted antibodies (SPARTA): methodology and applications

Sara D’Angelo,
Fernanda Staquicini,
Fortunato Ferrara,
Daniela Staquicini,
Geetanjali Sharma,
Christy Tarleton,
Huynh Nguyen,
Leslie Naranjo,
Richard Sidan,
Wadih Arap,
Andrew Bradbury,
Renata Pasqualini,

2018 | JCI Insight 3(9)

View Publication

Many routes to an antibody heavy-chain CDR3: necessary, yet insufficient for specific binding

Sara D’Angelo,
Fortunato Ferrara,
Leslie Naranjo,
M. Frank Erasmus,
Peter Hraber,
Andrew Bradbury,

2018 | Frontiers in Immunology 9

View Publication

Selected Prior Publications

High-throughput screening of single-chain antibodies using multiplexed flow cytometry

J Ayriss,
T Woods,
P Pavlik,
Andrew Bradbury,

2007 | J Proteome Res 6

View Publication

Eliminating helper phage from phage display

L Chasteen,
J Ayriss,
P Pavlik,
Andrew Bradbury,

2006 | Nucleic acids research 34

View Publication

Recombinatorial cloning using heterologous lox sites

R W Siegel,
N Velappan,
P Pavlik,
L Chasteen,
Andrew Bradbury,

2004 | Genome Res 14

View Publication

Selecting open reading frames from DNA

P Zacchi,
D Sblattero,
F Florian,
R Marzari,
Andrew Bradbury,

2003 | Genome Research 13

View Publication

Find out more about

what we do

Discover our Antibody Libraries and what makes us different.

Our team of highly collaborative, creative, hard-working professionals.